Authors


Mark B. Abelson, MD, CM, FRCS(C)

Latest:

Double concentration of olopatadine controls allergies all day

Wailea, HI-Olopatadine 0.2% (Patanol, Alcon) significantly reduced itching and redness for 24 hours, according to the results of a study presented at the annual meeting of the Western Society of Allergy, Asthma & Immunology.


Barbara Wright, CID

Latest:

Easy ways to create eye-catching displays

Visual merchandising is the art of displaying merchandise to encourage sales. Dispensing ophthalmology practices can create eye-catching displays by following some simple rules. Grouping frames by price point and brand helps to organize options for the customer. Displays can highlight individual brands through repetition, a pyramid design, using odd, rather than even numbers of items, considering the texture of background materials, and more.


L. Neal Freeman, MD, MBA,FACS

Latest:

Poor corporate governance makes business headlines

Business publications have been dominated recently by stories of corporate tricks, distortions, falsehoods, and a wide variety of other malfeasance. Corporate governance is thus receiving attention like never before. It has been a topic of major concern at the executive, legislative, and judicial branches of government as well as in society at large.


Kerry D. Solomon, MD

Latest:

Unique model illustrates fluidic flow during torsional phaco

Charleston, SC-Torsional phacoemulsification, which is accomplished with the OZil handpiece (Alcon Laboratories), is the newest incarnation of a phacoemulsification process that has remained virtually unchanged for 4 decades, since Charles Kelman, MD, introduced ultrasonic phacoemulsification. The improvements promised by this torsional technology include less dispersion of nuclear fragments, improved cutting performance, and improved thermal safety profile.


Charles Slonim, MD

Latest:

Corticosteroid shown to be safe for long-term SAC control

Tampa, FL-Loteprednol etabonate ophthalmic suspension 0.2% (Alrex, Bausch & Lomb Pharmaceuticals and Pharmos Corp.), the first corticosteroid specifically designed for signs and symptoms of seasonal allergic conjunctivitis (SAC), is safe for long-term use, according to a recent multicenter study.


Richard L. Anderson, MD

Latest:

Facial anatomy key to optimal use of botulinum toxin

Botulinum toxin type A effect is usually seen 2 to 3 days following injection, with maximal effect at approximately 2 weeks. Touch-ups are not recommended until 2 weeks have passed.


Michael T. Yen, MD

Latest:

Exposures of porous orbital implants can be avoided

In the past decade, porous orbital implants have become the implant of choice for many surgeons managing the anophthalmic socket after enucleation or evisceration. By permitting fibrovascular ingrowth, these porous implants are better able to resist infection, migration, and extrusion when compared with acrylic or silicone implants.


Cheryl Guttman Krader, BS, Pharm

Latest:

GA therapy demonstrates continuous, sustained effects of pegcetacoplan over time

Physician offers "real talk" on pros and cons that offers surgeons and patients decision-making insights.


Manus Kraff, MD

Latest:

Tracker aids centration for performing hyperopic LASIK

Chicago-Improved centration with a good-quality eye tracker is essential to address many of the issues involved with hyperopic LASIK, according to refractive surgeon Manus Kraff, MD.


Julia Talsma

Latest:

Is a specialty ASC in your plans?

Las Vegas-The numbers speak for themselves. Today, there are between 4,500 and 5,000 certified ambulatory surgery centers (ASCs) in the United States-outpacing the number of hospitals offering outpatient surgical procedures. More ASCs are expected to sprout up around the country at a rate of about 8% per year.


Janet L. Davis, MD

Latest:

A 19-year-old female has transient black spots, headaches

A 19-year-old Latin female presented to the Bascom Palmer emergency room complaining of transient black spots in the right eye.


John S. Grande, CFP?

Latest:

Reverse mortgage might ease burden of fixed income

Q My parents are living on a fixed income. Lately, their monthly expenses have begun to exceed their income. The only real asset they own is their home, which is paid off. It is not important to me to inherit their house, but I also don't want to have to subsidize their income if I don't need to. How could they use the equity in their home to augment their cash flow, without selling it?


Frank A. Bucci Jr., MD

Latest:

High- versus medium-add multifocal IOLs

Medium-add multifocal addresses the most likely source of dissatisfaction with contemporary multifocal IOLs: Intermediate vision


Parag Parekh, MD, MPA

Latest:

Thinking one step ahead

Use the time in residency to think one step ahead. 'If I were the attending, what would I do?'


Beth Thomas Hertz

Latest:

Ophthalmologists slightly better off than primary care colleagues

Ophthalmologists expressed a little more optimism than primary-care physicians, when asked to evaluate the financial state of their practices in a national survey conducted in 2011.



Jennifer A. Webb.

Latest:

New FDA report criticizes STAAR Surgical plant.

Monrovia, CA-STAAR Surgical Co. has hired a new vice president of quality, regulatory, and clinical affairs to work with the FDA, which has outlined 36 points about the condition of STAAR Surgical's manufacturing facility in a continuing investigation of the company.


Trudy F. Grande, CFPs

Latest:

SUV may qualify for tax break if used primarily for business

The IRS issued proposed regulations that have all but eliminated the fear of making bad decisions and essentially allow a 'stretchout' IRA for everyone.


John J.

Latest:

SUV may qualify for tax break if used primarily for business

The IRS issued proposed regulations that have all but eliminated the fear of making bad decisions and essentially allow a 'stretchout' IRA for everyone.




Katrina Norfleet

Latest:

ARVO gears up for 2014

It is not too early for members of the vision science community to make plans for the 2014 meeting of the Association for Research in Vision and Ophthalmology (ARVO).


Ophthalmology Times Staff Reports

Latest:

Visionary in Eye Care Award winners announced at EyeCon 2023

Inaugural awards honor 3 residents in ophthalmology, optometry, and retina


Eric Donnenfeld, MD

Latest:

Five secrets to success with co-management

Five ophthalmologists share how to make the most of a co-managed relationship for smoother patient handoff, improved preoperative experiences, and better postoperative outcomes.


Rose Schneider Krivich

Latest:

Eyewear holder gives patients place to store glasses during eye exam

William Neusidl, MD, invents eyewear holder that attaches to slit lamp table, gives patients safe place for glasses



Michelle Dalton

Latest:

Migraines, retinal perfusion: Pain for physicians, patients

OCT-A detected microcirculatory disturbances during acute post-aural migraine attacks may be an important tool in elucidating the pathophysiological relationship between migraine, aura, and ischemia.


Nathan Radcliffe, MD

Latest:

Breaking down the dorzolamide shortage

Our supply of dorzolamide, long a first-line glaucoma therapy used alone or in fixed combination with timolol, has recently proven unreliable.


Jodie Luchs, MD

Latest:

What cataract surgeons don’t know can hurt premium IOL outcomes

The majority of cataract patients likely have significant tear film disturbances that can affect their preoperative measurements and postoperative satisfaction with cataract surgery.


Michele Barrere

Latest:

IRIS Registry, ophthalmology’s moon shot?

In New Orleans, the theme song “The Saints Go Marching In,” sings the famous line, “I want to be in that Number.” The American Academy of Ophthalmology is hoping that thousands of its members will want to be in that number too-the Intelligent Research in Sight (IRIS) Registry, formally introduced on Sunday.

© 2024 MJH Life Sciences

All rights reserved.